Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 04-2023 | 01-2023 | 10-2022 | 07-2022 | 04-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,348 | 16,705 | 2,933 | 2,346 | 19,131 |
| Marketable Securities | 16,894 | 16,370 | 35,733 | 30,311 | N/A |
| Receivables | 669 | 543 | 891 | 559 | 500 |
| TOTAL | $27,102 | $33,864 | $39,687 | $33,492 | $19,836 |
| Non-Current Assets | |||||
| PPE Net | 328 | 335 | 313 | 324 | 348 |
| Intangibles | 307 | 347 | 401 | 441 | 487 |
| Other Non-Current Assets | 300 | 327 | 369 | 396 | 419 |
| TOTAL | $935 | $1,009 | $1,083 | $1,161 | $1,254 |
| Total Assets | $28,037 | $34,873 | $40,770 | $34,652 | $21,090 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,202 | 4,591 | 3,574 | 1,730 | 2,031 |
| TOTAL | $4,314 | $4,700 | $3,682 | $1,834 | $2,132 |
| Non-Current Liabilities | |||||
| TOTAL | $42 | $72 | $106 | $135 | $165 |
| Total Liabilities | $4,356 | $4,772 | $3,788 | $1,969 | $2,297 |
| Shareholders' Equity | |||||
| Common Shares | 81,809 | 82,420 | 86,215 | 76,359 | 59,668 |
| Retained earnings | -71,154 | -64,744 | -61,499 | -55,149 | -51,405 |
| Other shareholders' equity | 0 | 2,448 | 2,561 | 2,745 | 2,808 |
| TOTAL | $23,681 | $30,101 | $36,982 | $32,683 | $18,793 |
| Total Liabilities And Equity | $28,037 | $34,873 | $40,770 | $34,652 | $21,090 |